Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Cucchetti

Showing results (231-240 of 301) with videos related to

Pageof 31
Sort By:
European Radiology|April 1, 2020
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisationCristina Mosconi, Alessandro Cucchetti, Antonio Bruno, et al.
The American Surgeon|April 5, 2012
Hepatocellular carcinomas and primary liver tumors as predictive factors for postoperative mortality after liver resection: a meta-analysis of more than 35,000 hepatic resectionsGiovanni Ramacciato, Francesco D'Angelo, Rossella Baldini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2013
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patientsAnnagiulia Gramenzi, Sara Tedeschi, Maria Chiara Cantarini, et al.
Journal of Transplantation|September 24, 2010
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinomaMatteo Cescon, Matteo Ravaioli, Gian Luca Grazi, et al.
Clinical Transplantation|March 3, 2005
Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantationNicola De Ruvo, Alessandro Cucchetti, Augusto Lauro, et al.
Transplantation|July 9, 2005
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantationNicola De Ruvo, Alessandro Cucchetti, Augusto Lauro, et al.
Medicine|April 14, 2017
Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameterJian-Hong Zhong, Ling-Hui Pan, Yan-Yan Wang, et al.
The American Surgeon|December 15, 2010
Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinomaGiovanni Ramacciato, Giuseppe Nigri, Riccardo Bellagamba, et al.
Surgery|March 7, 2025
Outcomes after pancreatoduodenectomy and total pancreatectomy in patients with a high-risk pancreatic anastomosis: An entropy balance analysisGiovanni Capretti, Claudio Ricci, Serena Langella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 24, 2012
Long-term antiviral treatment for recurrent hepatitis C after liver transplantationValentina Rosa Bertuzzo, Matteo Cescon, Maria Cristina Morelli, et al.
Pageof 31

Showing results (231-240 of 301) with videos related to

Sort By:
Pageof 31
European Radiology|April 1, 2020
Radiomics of cholangiocarcinoma on pretreatment CT can identify patients who would best respond to radioembolisationCristina Mosconi, Alessandro Cucchetti, Antonio Bruno, et al.
The American Surgeon|April 5, 2012
Hepatocellular carcinomas and primary liver tumors as predictive factors for postoperative mortality after liver resection: a meta-analysis of more than 35,000 hepatic resectionsGiovanni Ramacciato, Francesco D'Angelo, Rossella Baldini, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 22, 2013
Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patientsAnnagiulia Gramenzi, Sara Tedeschi, Maria Chiara Cantarini, et al.
Journal of Transplantation|September 24, 2010
Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinomaMatteo Cescon, Matteo Ravaioli, Gian Luca Grazi, et al.
Clinical Transplantation|March 3, 2005
Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantationNicola De Ruvo, Alessandro Cucchetti, Augusto Lauro, et al.
Transplantation|July 9, 2005
Preliminary results of a "prope" tolerogenic regimen with thymoglobulin pretreatment and hepatitis C virus recurrence in liver transplantationNicola De Ruvo, Alessandro Cucchetti, Augusto Lauro, et al.
Medicine|April 14, 2017
Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameterJian-Hong Zhong, Ling-Hui Pan, Yan-Yan Wang, et al.
The American Surgeon|December 15, 2010
Univariate and multivariate analysis of prognostic factors in the surgical treatment of hilar cholangiocarcinomaGiovanni Ramacciato, Giuseppe Nigri, Riccardo Bellagamba, et al.
Surgery|March 7, 2025
Outcomes after pancreatoduodenectomy and total pancreatectomy in patients with a high-risk pancreatic anastomosis: An entropy balance analysisGiovanni Capretti, Claudio Ricci, Serena Langella, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 24, 2012
Long-term antiviral treatment for recurrent hepatitis C after liver transplantationValentina Rosa Bertuzzo, Matteo Cescon, Maria Cristina Morelli, et al.
Pageof 31